1 - 25 of
41
results
for author:"Ding K."
in Literature Citations
| Induced expression of the IER5 gene by gamma-ray irradiation and its involvement in cell cycle checkpoint control and survival. Ding K.K., Shang Z.F., Hao C., Xu Q.Z., Shen J.J., Yang C.J., Xie Y.H., Qiao C., Wang Y., Xu L.L. et al. Radiat Environ Biophys 48:205-213(2009) · Mapped (2) |
| Migfilin, a molecular switch in regulation of integrin activation. Ithychanda S.S., Das M., Ma Y.Q., Ding K., Wang X., Gupta S., Wu C., Plow E.F., Qin J. J. Biol. Chem. 284:4713-4722(2009) · Mapped (3) |
| Gamma-ray up-regulated holocarboxylase synthetase gene. Ding K., Yang C., Shen J., Xu L., Li Y., Zhou P., Zeng Y. Cell. Mol. Neurobiol. 29:383-389(2009) · Mapped (2) |
| Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells. Ding K., Su Y., Pang L., Lu Q., Wang Z., Zhang S., Zheng S., Mao J., Zhu Y. Carcinogenesis 30:35-42(2009) · Mapped (1) |
| Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Liu Z., Fu Q., Lv J., Wang F., Ding K. J. Exp. Clin. Cancer Res. 27:51-51(2008) · Mapped (15) |
| Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. Zhu C.Q., da Cunha Santos G., Ding K., Sakurada A., Cutz J.C., Liu N., Zhang T., Marrano P., Whitehead M., Squire J.A. et al. J. Clin. Oncol. 26:4268-4275(2008) · Mapped (23) |
| Targeted disruption of the Lasp-1 gene is linked to increases in histamine-stimulated gastric HCl secretion. Chew C.S., Chen X., Bollag R.J., Isales C., Ding K.H., Zhang H. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G37-G44(2008) · Mapped (2) |
| Molecular population genetics of PCSK9: a signature of recent positive selection. Ding K., Kullo I.J. Pharmacogenet. Genomics 18:169-179(2008) · Mapped (4) |
| HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery. Dioum E.M., Clarke S.L., Ding K., Repa J.J., Garcia J.A. Invest. Ophthalmol. Vis. Sci. 49:2714-2720(2008) · Mapped (2) |
| Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer. Tsao M.S., Aviel-Ronen S., Ding K., Lau D., Liu N., Sakurada A., Whitehead M., Zhu C.Q., Livingston R., Johnson D.H. et al. J. Clin. Oncol. 25:5240-5247(2007) · Mapped (8) |
| Evidence for positive selection in the C-terminal domain of the cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14 primate species. Ding K., McDonough S.J., Kullo I.J. |
| Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions. Wang H., Ding K., Zhang Y., Jin L., Kullo I.J., He F. Pharmacogenet. Genomics 17:667-678(2007) · Mapped (8) |
| Fibrinogen controls human platelet fibronectin internalization and cell-surface retention. Zhai Z., Wu J., Xu X., Ding K., Ni R., Hu W., Sun Z., Ni H. J. Thromb. Haemost. 5:1740-1746(2007) · Mapped (37) |
| Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. Oktay Y., Dioum E., Matsuzaki S., Ding K., Yan L.J., Haller R.G., Szweda L.I., Garcia J.A. J. Biol. Chem. 282:11750-11756(2007) · Mapped (9) |
| Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10. Seve P., Lai R., Ding K., Winton T., Butts C., Mackey J., Dumontet C., Dabbagh L., Aviel-Ronen S., Seymour L. et al. Clin. Cancer Res. 13:994-999(2007) · Mapped (22) |
| Mutation screening of BMP4, BMP7, HOXA4 and HOXB6 genes in Chinese patients with hypospadias. Chen T., Li Q., Xu J., Ding K., Wang Y., Wang W., Li S., Shen Y. Eur. J. Hum. Genet. 15:23-28(2007) · Mapped (12) |
| Effects of glucose-dependent insulinotropic peptide on behavior. Ding K.H., Zhong Q., Xie D., Chen H.X., Della-Fera M.A., Bollag R.J., Bollag W.B., Gujral R., Kang B., Sridhar S. et al. Peptides 27:2750-2755(2006) · Mapped (4) |
| Molecular basis for PKR activation by PACT or dsRNA. Li S., Peters G.A., Ding K., Zhang X., Qin J., Sen G.C. Proc. Natl. Acad. Sci. U.S.A. 103:10005-10010(2006) · Mapped (6) |
| Protein interaction analysis of ST14 domains and their point and deletion mutants. Ge W., Hu H., Ding K., Sun L., Zheng S. J. Biol. Chem. 281:7406-7412(2006) · UniProtKB (2) · Mapped (3) |
| Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Ding K.H., Wang Z.Z., Hamrick M.W., Deng Z.B., Zhou L., Kang B., Yan S.L., She J.X., Stern D.M., Isales C.M. et al. Biochem. Biophys. Res. Commun. 340:1091-1097(2006) · Mapped (14) |
| Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. Ding K., Lopez-Burks M., Sanchez-Duran J.A., Korc M., Lander A.D. J. Cell Biol. 171:729-738(2005) · Mapped (6) |
| Effect of SNC19/ST14 gene overexpression on invasion of colorectal cancer cells. Ding K.F., Sun L.F., Ge W.T., Hu H.G., Zhang S.Z., Zheng S. World J. Gastroenterol. 11:5651-5654(2005) · Mapped (4) |
| Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Xie D., Cheng H., Hamrick M., Zhong Q., Ding K.H., Correa D., Williams S., Mulloy A., Bollag W., Bollag R.J. et al. Bone 37:759-769(2005) · Mapped (1) |
| Carboxy-terminal PTH fragments stimulate [3H]thymidine incorporation in vascular endothelial cells. Ding K.H., Zhong Q., Xie D., Xu J., Bollag R.J., Bollag W.B., Isales C.M. Peptides 26:853-862(2005) · Mapped (1) |
| Retinal disease in mice lacking hypoxia-inducible transcription factor-2alpha. Ding K., Scortegagna M., Seaman R., Birch D.G., Garcia J.A. Invest. Ophthalmol. Vis. Sci. 46:1010-1016(2005) · Mapped (2) |
